Answers are grounded in this paper and cite their sources.
Antibody-mediated rejection (ABMR) is a significant cause of graft loss. The diagnosis of ABMR was historically made by three criteria: morphological evidence of acute tissue injury, presence of donor-specific antibodies (DSA), and C4d staining in peritubular capillaries (PTC) (Banff). This study aims to analyze the clinical and histological characteristics of patients (ptes) with ABMR with and without of circulating donor-specific anti-human leukocyte antigen (HLA) DSA, and graft function.
No takes yet. Share an insight, caveat, or question.
Avallay et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: